Telcon Inc Cash Flow Conversion Efficiency
Telcon Inc cash flow conversion efficiency. Based on the latest financial reports, Telcon Inc (200230) has a cash flow conversion efficiency ratio of -0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.56 Billion ≈ $-1.06 Million USD) by net assets (₩97.42 Billion ≈ $66.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Telcon Inc (2013–2025)
Cash flow conversion efficiency of Telcon Inc from 2013 to 2025. This chart illustrates how Telcon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 200230 share price today for real-time trading data and today's change.
Telcon Inc Cash Flow Conversion Ratio Explained
Telcon Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Telcon Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Telcon Inc ranked by their cash flow conversion efficiency. Also see market cap of Telcon Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Metal Hawk Ltd
AU:MHK
|
-0.079x |
|
Redivium Ltd
AU:RIL
|
2.594x |
|
Victrex plc
LSE:VCT
|
0.092x |
|
Hateks Hatay Tekstil Isletmeleri AS
IS:HATEK
|
-0.099x |
|
Titan Logix Corp.
V:TLA
|
-0.028x |
|
ERG S.A.
WAR:ERG
|
0.048x |
|
CoinSmart Financial Inc
NEO:SMRT
|
-0.279x |
|
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ:GDTC
|
-0.299x |
Annual Cash Flow Conversion Efficiency for Telcon Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Telcon Inc from 2013 to 2025. Review free cash flow generation of Telcon Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩108.82 Billion ≈ $73.74 Million |
₩1.67 Billion ≈ $1.13 Million |
0.015x | +4.46% |
| 2024-12-31 | ₩83.13 Billion ≈ $56.34 Million |
₩1.22 Billion ≈ $825.99K |
0.015x | +235.60% |
| 2023-12-31 | ₩104.94 Billion ≈ $71.12 Million |
₩-1.13 Billion ≈ $-768.96K |
-0.011x | +56.54% |
| 2022-12-31 | ₩84.12 Billion ≈ $57.01 Million |
₩-2.09 Billion ≈ $-1.42 Million |
-0.025x | -639.51% |
| 2021-12-31 | ₩106.58 Billion ≈ $72.23 Million |
₩-358.56 Million ≈ $-242.99K |
-0.003x | -110.96% |
| 2020-12-31 | ₩91.34 Billion ≈ $61.90 Million |
₩2.80 Billion ≈ $1.90 Million |
0.031x | -30.20% |
| 2019-12-31 | ₩114.02 Billion ≈ $77.27 Million |
₩5.01 Billion ≈ $3.40 Million |
0.044x | +173.22% |
| 2018-12-31 | ₩154.03 Billion ≈ $104.38 Million |
₩-9.25 Billion ≈ $-6.27 Million |
-0.060x | +34.47% |
| 2017-12-31 | ₩107.69 Billion ≈ $72.98 Million |
₩-9.87 Billion ≈ $-6.69 Million |
-0.092x | -22.16% |
| 2016-12-31 | ₩65.96 Billion ≈ $44.70 Million |
₩-4.95 Billion ≈ $-3.35 Million |
-0.075x | -245.56% |
| 2015-12-31 | ₩43.99 Billion ≈ $29.81 Million |
₩2.27 Billion ≈ $1.54 Million |
0.052x | +51.13% |
| 2014-12-31 | ₩43.21 Billion ≈ $29.28 Million |
₩1.47 Billion ≈ $998.50K |
0.034x | -93.92% |
| 2013-12-31 | ₩22.51 Billion ≈ $15.25 Million |
₩12.62 Billion ≈ $8.55 Million |
0.561x | -- |
About Telcon Inc
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.